Vicarious Surgical Inc. (NYSE:RBOT) Sees Significant Growth in Short Interest

Vicarious Surgical Inc. (NYSE:RBOT) was the recipient of a significant increase in short interest during the month of January. As of January 15th, there was short interest totaling 309,143 shares, an increase of 120.1% from the December 31st total of 140,432 shares. Based on an average daily volume of 266,613 shares, the short-interest ratio is presently 1.2 days. Approximately 5.2% of the shares of the company are sold short. Approximately 5.2% of the shares of the company are sold short. Based on an average daily volume of 266,613 shares, the short-interest ratio is presently 1.2 days.

Wall Street Analyst Weigh In

RBOT has been the topic of a number of recent research reports. BTIG Research restated a “neutral” rating on shares of Vicarious Surgical in a research note on Friday, December 12th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Vicarious Surgical in a report on Wednesday, January 21st. Finally, Wall Street Zen downgraded shares of Vicarious Surgical from a “hold” rating to a “sell” rating in a research report on Saturday. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and an average target price of $7.00.

Hedge Funds Weigh In On Vicarious Surgical

A number of hedge funds have recently modified their holdings of RBOT. Dimensional Fund Advisors LP grew its stake in Vicarious Surgical by 22.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock valued at $110,000 after acquiring an additional 3,615 shares in the last quarter. Connective Capital Management LLC acquired a new stake in shares of Vicarious Surgical during the third quarter worth approximately $169,000. Finally, DNB Asset Management AS boosted its holdings in shares of Vicarious Surgical by 12.1% during the second quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock worth $219,000 after purchasing an additional 3,154 shares during the period. 47.27% of the stock is currently owned by institutional investors and hedge funds.

Vicarious Surgical Stock Up 6.2%

Shares of RBOT opened at $2.21 on Friday. The firm has a market capitalization of $14.48 million, a PE ratio of -0.24 and a beta of 1.52. The firm has a 50-day moving average price of $2.50 and a 200 day moving average price of $5.15. Vicarious Surgical has a 52-week low of $1.80 and a 52-week high of $16.35.

Vicarious Surgical (NYSE:RBOT) last posted its quarterly earnings data on Wednesday, November 12th. The company reported ($1.91) EPS for the quarter, topping analysts’ consensus estimates of ($2.37) by $0.46. On average, equities analysts expect that Vicarious Surgical will post -10.89 EPS for the current year.

About Vicarious Surgical

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.